耐阿莫西林幽门螺杆菌对其他青霉素的敏感性。
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins.
作者信息
Dore M P, Graham D Y, Sepulveda A R, Realdi G, Osato M S
机构信息
Department of Medicine, VA Medical Center, and Baylor College of Medicine, Houston, Texas 77030, USA.
出版信息
Antimicrob Agents Chemother. 1999 Jul;43(7):1803-4. doi: 10.1128/AAC.43.7.1803.
Abstract
The sensitivities to penicillins and to a penicillin and beta-lactamase inhibitor combination agent were determined for Helicobacter pylori strains that were sensitive, moderately resistant, or highly resistant to amoxicillin. All strains were resistant to nafcillin and oxacillin. Moderately resistant strains showed an intermediate zone of inhibition to ticarcillin, mezlocillin, piperacillin, and amoxicillin-clavulanic acid. High-level resistance was associated with the smallest zone size for all penicillins tested.
摘要
对阿莫西林敏感、中度耐药或高度耐药的幽门螺杆菌菌株测定了对青霉素以及青霉素与β-内酰胺酶抑制剂联合制剂的敏感性。所有菌株对萘夫西林和苯唑西林均耐药。中度耐药菌株对替卡西林、美洛西林、哌拉西林和阿莫西林-克拉维酸呈现中间抑菌圈。对所有测试的青霉素而言，高水平耐药与最小抑菌圈大小相关。
相似文献
1
Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins.
Antimicrob Agents Chemother. 1999 Jul;43(7):1803-4. doi: 10.1128/AAC.43.7.1803.
2
Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori.
Helicobacter. 1999 Sep;4(3):154-61. doi: 10.1046/j.1523-5378.1999.99310.x.
3
Amoxycillin-clavulanate versus methicillin or isoxazolyl penicillins for treatment of Staphylococcus aureus infections.
J Antimicrob Chemother. 1995 Mar;35(3):435-41. doi: 10.1093/jac/35.3.435.
4
Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
J Antimicrob Chemother. 2003 Dec;52(6):1018-21. doi: 10.1093/jac/dkg474. Epub 2003 Oct 29.
5
Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.
Antimicrob Agents Chemother. 2001 Mar;45(3):962-5. doi: 10.1128/AAC.45.3.962-965.2001.
6
Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.
Antimicrob Agents Chemother. 2000 Dec;44(12):3368-73. doi: 10.1128/AAC.44.12.3368-3373.2000.
7
Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori.
Antimicrob Agents Chemother. 2002 Jul;46(7):2229-33. doi: 10.1128/AAC.46.7.2229-2233.2002.
8
Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.
Antimicrob Agents Chemother. 1999 Nov;43(11):2702-9. doi: 10.1128/AAC.43.11.2702.
9
Detection of intrinsic oxacillin resistance in non-multiresistant, oxacillin-resistant Staphylococcus aureus (NORSA).
J Antimicrob Chemother. 2003 Feb;51(2):468-70. doi: 10.1093/jac/dkg064.
10
Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp.
J Antimicrob Chemother. 2003 Jul;52(1):120-2. doi: 10.1093/jac/dkg297. Epub 2003 Jun 12.
引用本文的文献
1
Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection.
Biomed Res Int. 2014;2014:158520. doi: 10.1155/2014/158520. Epub 2014 Jun 5.
2
Furazolidone, co-amoxiclav, colloidal bismuth subcitrate, and esomeprazole for patients who failed to eradicate Helicobacter pylori with triple therapy.
Dig Dis Sci. 2009 Sep;54(9):1953-7. doi: 10.1007/s10620-008-0582-6. Epub 2008 Dec 5.
3
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.
Antimicrob Agents Chemother. 2006 Sep;50(9):3062-9. doi: 10.1128/AAC.00036-06.
4
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
World J Gastroenterol. 2006 Aug 14;12(30):4888-91. doi: 10.3748/wjg.v12.i30.4888.
5
Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.
Antimicrob Agents Chemother. 2000 Dec;44(12):3368-73. doi: 10.1128/AAC.44.12.3368-3373.2000.
本文引用的文献
1
Amoxycillin tolerance in Helicobacter pylori.
J Antimicrob Chemother. 1999 Jan;43(1):47-54. doi: 10.1093/jac/43.1.47.
2
Treatment of Helicobacter pylori infection: a review of the world literature.
Helicobacter. 1996 Mar;1(1):6-19. doi: 10.1111/j.1523-5378.1996.tb00003.x.
3
Resistance of Helicobacter pylori to antibiotics.
Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:43-53. doi: 10.1046/j.1365-2036.11.s1.11.x.
4
Eradication of Helicobacter pylori: an objective assessment of current therapies.
Br J Clin Pharmacol. 1997 Mar;43(3):223-43. doi: 10.1046/j.1365-2125.1997.00551.x.
5
Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole.
Diagn Microbiol Infect Dis. 1996 Jan;24(1):37-41. doi: 10.1016/0732-8893(95)00252-9.
6
Review of Helicobacter pylori eradication regimens.
Scand J Gastroenterol Suppl. 1996;215:74-81.
7
Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.
Am J Gastroenterol. 1996 Jun;91(6):1072-6.
8
Use of penicillin-gradient and replicate plates for the demonstration of tolerance to penicillin in streptococci.
J Infect Dis. 1983 Sep;148(3):488-91. doi: 10.1093/infdis/148.3.488.
9
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.
Zotero 插件